Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
New Treatments for Myelofibrosis
Douglas Tremblay, Ruben Mesa
Mays Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New Treatments for Myelofibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Myelofibrosis
100%
Combination Therapy
80%
Therapeutic Procedure
80%
Janus Kinase Inhibitor
60%
Development
40%
Pathophysiology
20%
Symptom
20%
Patient
20%
Inpatient
20%
Spleen
20%
Pharmacology, Toxicology and Pharmaceutical Science
Myelofibrosis
100%
Janus Kinase Inhibitor
60%
Pathophysiology
20%
Telomerase
20%
Symptom
20%